Jim Myers || 25th April 2014 || News analysis || Policy and Politics | Regulation and Legislation | Geographies: North America United States
The commissioner of the U.S. Food and Drug Administration (FDA) drew laughter from a Washington, D.C. audience this week when she promised that the agency’s long-delayed deeming rules on e-cigarettes and other products were imminent.
Are you already a subscriber? login here Enjoy free subscription access Get access to premium content that is normally only available for subscribers. For the duration of a week, you can read our news analysis, identify market trends and understand upcoming changes in the industry, which will enable you to get ahead of your competitors. Benefits of subscription plans: Stay informed of any legal and market change in the sector that impacts your organization Maximise resources by getting market and legal data analysis daily in one place Make smart decisions by understanding how the regulatory and market landscape evolves Anticipate risks in your decisions by monitoring regulatory changes that impact your organization